Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway
Junchen Li, Lixun Huang, Zinan He, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

MicroRNAs in cancer metastasis: biological and therapeutic implications
Marie C. Sell, Charmaine A. Ramlogan‐Steel, Jason C. Steel, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Open Access | Times Cited: 26
Andrographolide Mitigates Cisplatin Resistance by Inhibiting SPP1 Regulated NF‐kB/iNOS/COX‐2 and PI3K/AKT Pathway in Cisplatin Resistant Cervical Carcinoma Cells
Akbar Pasha, Doneti Ravinder, Smita C. Pawar
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access | Times Cited: 1
Advances on Natural Abietane, Labdane and Clerodane Diterpenes as Anti-Cancer Agents: Sources and Mechanisms of Action
Rosaria Acquaviva, Giuseppe Antonio Malfa, Monica Rosa Loizzo, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4791-4791
Open Access | Times Cited: 32
Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing
Thiviyadarshini Rajasegaran, Chee Wun How, Anoosha Saud, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 451-451
Open Access | Times Cited: 16
Dissecting the Roles of PDCD4 in Breast Cancer
Qian Cai, Hsin‐Sheng Yang, Yi‐Chen Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 26
A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC
Yanmei Wang, Jia Zhou, Nan Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9392-9392
Open Access | Times Cited: 14
Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathway
Akbar Pasha, Kiran Kumar, S. K. Heena, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Diterpenes: Nature’s Hidden Gems of Immunomodulation
Jonas S. Almeida, André Correa de Oliveira, Carlos Eduardo de Castro Alves, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2250-2250
Open Access
A new era of cancer immunotherapy: vaccines and miRNAs
Gitika Sareen, Maneesh Mohan, Ashi Mannan, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
Bone mesenchymal stem cells (BMSCs)-derived exosomal microRNA-21-5p regulates Kruppel-like factor 3 (KLF3) to promote osteoblast proliferationin vitro
Murong You, Zisheng Ai, Ji‐Huan Zeng, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 11933-11944
Open Access | Times Cited: 22
The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer
Ekaterina A. Sidorova, Yury V. Zhernov, Marina A. Antsupova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1980-1980
Open Access | Times Cited: 11
Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma
Guodan Zeng, Xinyu Liu, H. Lv, et al.
Biology (2025) Vol. 14, Iss. 1, pp. 61-61
Open Access
Cancer chemoprevention: signaling pathways and strategic approaches
Junling Ren, Guangli Yan, Le Yang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Study on the mechanism of andrographolide activation
Qihan Cai, Weina Zhang, Yanan Sun, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 15
Identification and validation of an immune-derived multiple programmed cell death index for predicting clinical outcomes, molecular subtyping, and drug sensitivity in lung adenocarcinoma
Chunhong Li, Jiahua Hu, Xiling Jiang, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 9, pp. 2274-2295
Closed Access | Times Cited: 2
siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells
Supusson Pengnam, Purin Charoensuksai, Boon‐ek Yingyongnarongkul, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1196-1196
Open Access | Times Cited: 10
RASSF1A promotes radiosensitivity in nasopharyngeal carcinoma by promoting FoxO3a and inhibiting the Nrf2/TXNRD1 signaling pathway
Yishimei Si, Linghan Meng, Bingwen Zhang, et al.
Neoplasma (2023) Vol. 70, Iss. 05, pp. 633-644
Open Access | Times Cited: 4
In vitro and in silico evaluation of Andrographis paniculata ethanolic crude extracts on 3 fatty acid synthase expression on breast cancer cells
Nur Amanina Johari, Nur Anisa Sapi’i, Alvin Lu Jiunn Hieng, et al.
Biomedicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 1
Circ_SAR1A regulates the malignant behavior of lung cancer cells via the miR‐21‐5p/TXNIP axis
Yi Zhao, Ying Wan, Tianzhen He
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 5
Open Access | Times Cited: 6
A critical review of <i>Andrographis paniculata</i>
Xianghui Chen, Junze Ren, Jindong Yang, et al.
Medicinal Plant Biology (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer
Lea Ling‐Yu Kan, Ben Chung-Lap Chan, Ping‐Chung Leung, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5804-5804
Open Access | Times Cited: 3
Andrographolide-treated bone marrow mesenchymal stem cells-derived conditioned medium protects cardiomyocytes from injury by metabolic remodeling
Yanting Sun, Hao Xu, Bin Tan, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 3, pp. 2651-2662
Closed Access | Times Cited: 2
MiR-21 participates in the neuroprotection of diazoxide against hypoxic-ischemia encephalopathy by targeting PDCD4
Yuxia Chen, Hao Zeng, Huayan Liu
Brain Injury (2022) Vol. 36, Iss. 7, pp. 876-885
Closed Access | Times Cited: 4
Andrographolide enhances the antitumor activity of cisplatin by inhibiting the PI3K/AKT signaling pathway in bladder cancer
Lei Xuan, Ran Bi, Junnian Song, et al.
Research Square (Research Square) (2024)
Open Access
Andrographolide: A Review on Experimental Clinical Trials and Applications
Divya Teli, Dixa A. Vaghela, Amit Chaudhri, et al.
Journal of Experimental and Clinical Application of Chinese Medicine (2024), pp. 55-72
Open Access
Page 1 - Next Page

Scroll to top